Sorry, you need to enable JavaScript to visit this website.

Pfizer-BioNTech COVID-19 Vaccine (also known as BNT162b2)

This product information is intended only for residents of the United States.

Pfizer-BioNTech COVID-19 Vaccine (2023-2024 Formula) has not been approved or licensed by FDA, but has been authorized for emergency use by FDA, under an EUA to prevent Coronavirus Disease 2019 (COVID-19) for use in individuals 6 months through 11 years of age. The emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of the medical product under Section 564(b) (1) of the FD&C Act unless the declaration is terminated or authorization revoked sooner.  

Previous COVID-19 vaccines, including original monovalent COVID-19 vaccines and bivalent (original and Omicron BA.4/BA.5) mRNA COVID-19 vaccines, are no longer authorized for use in the United States. FDA and CDC guidance is to check inventory and dispose of previous COVID-19 vaccines according to state and local regulations.

for Consumers:

for Healthcare professionals: